IBDkb: an AI-enhanced integrative knowledge base for inflammatory bowel disease research and drug discovery
Database · 2026
DOI: 10.1093/database/baag038 ↗At a glance
Journal article in Database, 2026. Written by Liwen Tao and 11 co-authors. Institution: Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Clinical and Translation …. Major MEDLINE topics: Inflammatory Bowel Diseases, Drug Discovery, Knowledge Bases, Artificial Intelligence. 34 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, China Postdoctoral Science Foundation, China Association for Science and Technology.
Abstract (original language)
IBDkb (Inflammatory Bowel Disease Knowledge Base; https://www.biosino.org/ibdkb) is a freely accessible, integrated web-based platform that systematically curates and harmonizes multi-source data related to inflammatory bowel disease (IBD). To address the fragmentation and therapeutic gaps in existing specialized resources, IBDkb establishes a unified framework featuring advanced full-text search, interactive visualizations, cross-module knowledge graphs, and AI-powered utilities for real-time literature retrieval, trend analysis, text/PDF interpretation, and domain-specific conversational assistance. The platform currently integrates 98 453 research articles, 3390 clinical trials, 200 investigational drugs, 200 606 bioactive compounds, 103 therapeutic targets, 77 experimental models, 12 pathogenesis summaries, and 15 treatment strategies. These integrated tools facilitate efficient exploration of complex associations among drugs, targets, trials, and mechanisms, thereby accelerating hypothesis generation and translational research in IBD. The platform is openly available without registration and supports data downloads. A case study on structure-aware drug comparison further demonstrates its utility in facilitating cross-disease drug repositioning hypotheses.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Clinical and Translation Research Center, Shanghai First Maternity and Infant Hospital, School…
- State Key Laboratory of Genetic and Development of Complex Phenotypes, Fudan Microbiome Center, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200438, P. R. China.
- Shanghai Southgene Technology Co., Ltd, 351 Guo Shoujing Road, Shanghai 201203, China.
- National Genomics Data Center& Bio-Med Big Data Center, Chinese Academy of Sciences Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, 500 Caobao Road, Shan…
- Department of Colorectal Surgery, Zhongshan Hospital, Fudan University, 220 Handan Road, Shanghai 200032, P. R. China.
ORCID profiles: Guoqing Zhang, Dingfeng Wu
Funding
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- China Association for Science and Technology
- Tongji University
Cite
APA
Tao, L., Shi, S., Zhu, R., Liu, Z., Yang, B., Liu, L., Chen, W., Long, Q., Jiao, N., Zhang, G., Xu, P., & Wu, D. (2026). IBDkb: an AI-enhanced integrative knowledge base for inflammatory bowel disease research and drug discovery. Database. https://doi.org/10.1093/database/baag038
Vancouver
Tao L, Shi S, Zhu R, Liu Z, Yang B, Liu L, et al. IBDkb: an AI-enhanced integrative knowledge base for inflammatory bowel disease research and drug discovery. Database. 2026. doi:10.1093/database/baag038
BibTeX
@article{Tao2026,
author = {Tao, Liwen and Shi, Shiqing and Zhu, Ruixin and Liu, Zhuo and Yang, Bin and Liu, Lei and Chen, Wanning and Long, Qian and Jiao, Na and Zhang, Guoqing and Xu, Pingping and Wu, Dingfeng},
title = {IBDkb: an AI-enhanced integrative knowledge base for inflammatory bowel disease research and drug discovery},
journal = {Database},
year = {2026},
doi = {10.1093/database/baag038}
}
EUVIMED